Clinical characteristics and outcomes of PTLD following intestinal transplantation

Post‐transplant lymphoproliferative disease (PTLD) has the highest incidence following intestinal transplantation (ITx). Our center has seen a recent increase in PTLD. Our aim was to review a single‐center PTLD experience with a focus on clinical characteristics and outcomes. We completed a retrospective review of biopsy‐proven PTLD cases using a prospectively maintained database of 115 ITx recipients transplanted between 1991 and 2014. Nineteen (17%) ITx recipients developed 25 PTLD cases during a median follow‐up time of 6.4 (1.6‐14.6) years. The incidence of early PTLD was 6% (n = 7). There was a trend toward increased risk of PTLD in children compared with adults (P = .11) and a significantly increased risk of PTLD in re‐ITx compared with primary ITx recipients (P = .03). Most PTLD cases were diagnosed between 2010 and 2014 (n = 14). All early PTLD cases were EBV+ on in situ hybridization. Overall graft and patient survival are 68% and 74%, respectively. Second episodes of PTLD were diagnosed in 43% of surviving pediatric patients. Our program has a low incidence of early PTLD with overall excellent graft and patient survival following diagnosis. However, we have also seen a rising incidence of late PTLD. The cause of the increase is unknown as no major changes in immunosuppression protocols have occurred since 1999.

• Publication year

  2018

• Venue

  Clinical Transplantation

• Publication date

  2018-07-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ctr.13313PMID 29888807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients

  2017cited by this paper
• The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

  2016cited by this paper
• Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report

  2016cited by this paper
• Plasmacytoma-like Posttransplant Lymphoproliferative Disorder in a Pediatric Heart Transplant Recipient

  2016cited by this paper
• Imaging findings in children with proliferative disorders following multivisceral transplantation

  2015cited by this paper
• Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

  2015cited by this paper
• Intestinal Transplant Registry Report: Global Activity and Trends

  2015cited by this paper
• mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells

  2014cited by this paper
• Plasmacytoma‐like post‐transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipients

  2013cited by this paper
• Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder

  2013cited by this paper
• The World Health Organization Classification of Lymphoid Neoplasms

  2013cited by this paper
• Post‐transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: Incidence, clinical features and outcome

  2013cited by this paper
• Clinicopathologic features of post‐transplant lymphoproliferative disorders arising after pediatric small bowel transplant

  2013cited by this paper
• Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis.

  2013cited by this paper
• Rapidly progressive post-transplant lymphoproliferative disease following withdrawal of sirolimus.

  2012cited by this paper
• Low‐Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report

  2012cited by this paper
• Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

  2011cited by this paper
• Pretransplant Predictors of Survival After Intestinal Transplantation: Analysis of a Single-Center Experience of More Than 100 Transplants

  2010cited by this paper
• Lymphoproliferative Disorders and De Novo Malignancies in Intestinal and Multivisceral Recipients: Improved Outcomes With New Outlooks

  2009cited by this paper
• Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

  2009cited by this paper
• Immune surveillance of tumors.

  2007cited by this paper
• Post‐transplant multiple myeloma in a pediatric renal transplant patient

  2006cited by this paper
• Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.

  2006cited by this paper
• Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.

  2006cited by this paper
• Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus.

  2005cited by this paper
• 2003 Report of the Intestine Transplant Registry: A New Era Has Dawned

  2005cited by this paper
• Molecular effects of cyclosporine and oncogenesis: a new model.

  2004cited by this paper
• Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation.

  2002cited by this paper
• Post‐Transplant Lymphoproliferative Disorder in the United States: Young Caucasian Males are at Highest Risk

  2002cited by this paper
• Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation

  2001cited by this paper
• Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

  2000cited by this paper
• Posttransplant lymphoproliferative disorders in small bowel allograft recipients.

  2000cited by this paper
• Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.

  2000cited by this paper
• Clinical intestinal transplantation: new perspectives and immunologic considerations.

  1998cited by this paper
• Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation.

  1996cited by this paper
• Clinical intestinal transplantation.

  1993cited by this paper
• Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

  1989cited by this paper

• Update on intestinal transplantation for the intensivist.

  2026cites this paper
• Viral load preemptive monitoring in the post-transplant immunocompromised population.

  2026cites this paper
• Deciphering Deception: Pancreatic Mass Presenting as Post-Transplant Lymphoproliferative Disorder

  2025cites this paper
• Primary Gastrointestinal B-Cell Lymphomas: A Clinicopathological Review

  2025cites this paper
• Subtype-specific progression of post-transplant lymphoproliferative disease (PTLD) in children: Implications for age-based surveillance and early intervention strategies.

  2025cites this paper
• Does the Organ Matter in PTLD Development in Solid Organ Transplant Recipients? A Multicenter Observational Study of Risk and Prognostic Factors

  2025cites this paper
• Adult and late adolescent complications of pediatric solid organ transplantation

  2024cites this paper
• Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation

  2024cites this paper
• Risk Factors Associated with PTLD Related Mortality in Adult Multivisceral Transplant Recipients - A Single Centre Cohort Study.

  2024cites this paper
• Intestinal and Multivisceral Transplantation: Complications.

  2023cites this paper
• Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults.

  2023cites this paper
• Post‐transplant lymphoproliferative disease in children, adolescents, and young adults

  2023cites this paper
• The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring

  2023cites this paper
• Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds.

  2023cites this paper
• Intra-arterial methylprednisolone for pediatric gastrointestinal post-transplant lymphoproliferative disorder

  2023cites this paper
• Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients

  2023cites this paper
• Endoscopy in the Surgically Altered Bowel.

  2022cites this paper
• Nondestructive versus advanced post‐transplant lymphoproliferative disorder in a single‐center pediatric kidney transplant population

  2022cites this paper
• Living Donor Intestinal Transplantation

  2022cites this paper
• Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review

  2022cites this paper
• Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells.

  2022cites this paper
• Late graft loss after intestinal transplantation.

  2021cites this paper
• Induction regimens and post‐transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single‐center experience

  2020cites this paper
• Beyond 10 years, with or without an intestinal graft: Present and future?

  2020cites this paper
• Current status of pediatric intestinal transplantation in the United States.

  2020cites this paper
• Factors Associated With 5- and 10-Year Survival After Intestinal Transplantation in Infants and Children

  2020cites this paper
• The role of endoscopy in the small intestinal transplant recipient: A review

  2020cites this paper
• Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: impact of mTOR inhibitors.

  2019cites this paper
• Imaging of intestinal transplantation.

  2019cites this paper
• Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper